000 | 01853 a2200493 4500 | ||
---|---|---|---|
005 | 20250517231423.0 | ||
264 | 0 | _c20190813 | |
008 | 201908s 0 0 eng d | ||
022 | _a1471-2431 | ||
024 | 7 |
_a10.1186/s12887-018-1220-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWaterfield, Thomas | |
245 | 0 | 0 |
_aThe "Petechiae in children" (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA - a study protocol. _h[electronic resource] |
260 |
_bBMC pediatrics _c07 2018 |
||
300 |
_a246 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDNA, Bacterial _xisolation & purification |
650 | 0 | 4 | _aDecision Support Techniques |
650 | 0 | 4 | _aEmergency Service, Hospital |
650 | 0 | 4 |
_aExanthema _xetiology |
650 | 0 | 4 |
_aFever _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMeningococcal Infections _xcomplications |
650 | 0 | 4 |
_aNeisseria meningitidis _xgenetics |
650 | 0 | 4 |
_aPoint-of-Care Testing _xeconomics |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aProcalcitonin _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aResearch Design |
700 | 1 | _aLyttle, Mark D | |
700 | 1 | _aFairley, Derek | |
700 | 1 | _aMckenna, James | |
700 | 1 | _aWoolfall, Kerry | |
700 | 1 | _aLynn, Fiona | |
700 | 1 | _aManey, Julie-Ann | |
700 | 1 | _aRoland, Damian | |
700 | 1 | _aWeir, Aoife | |
700 | 1 | _aShields, Michael D | |
773 | 0 |
_tBMC pediatrics _gvol. 18 _gno. 1 _gp. 246 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12887-018-1220-x _zAvailable from publisher's website |
999 |
_c28683944 _d28683944 |